| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |